By Drug Target Review –
Regenerative medicine is set to be transformed by induced pluripotent stem cells (iPSCs). These versatile cells can be reprogrammed to become virtually any cell type in the human body, offering groundbreaking possibilities for treating a wide range of conditions, from genetic disorders to degenerative diseases. Their capacity to provide an unlimited supply of cells means that iPSCs could revolutionise cell therapies.
Unlike embryonic stem cells, iPSCs avoid the ethical dilemmas tied to embryo use, broadening access to innovative therapeutic applications. However, despite their promise, iPSCs face significant challenges that must be addressed before they can fully realise their potential as a cornerstone of regenerative medicine.
